These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34413851)

  • 1. Case Report: Abscopal Effect of Microwave Ablation in a Patient With Advanced Squamous NSCLC and Resistance to Immunotherapy.
    Shao C; Yang M; Pan Y; Xie D; Chen B; Ren S; Zhou C
    Front Immunol; 2021; 12():696749. PubMed ID: 34413851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of local therapy for oligoprogressive disease after programmed cell death 1 blockade in advanced non-small cell lung cancer.
    Kagawa Y; Furuta H; Uemura T; Watanabe N; Shimizu J; Horio Y; Kuroda H; Inaba Y; Kodaira T; Masago K; Fujita S; Niimi A; Hida T
    Cancer Sci; 2020 Dec; 111(12):4442-4452. PubMed ID: 32770608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of combined immunotherapy and antiangiogenic therapy for advanced non-small cell lung cancer: A two-center retrospective study.
    Yao J; Wang Z; Sheng J; Wang H; You L; Zhu X; Pan H; Han W
    Int Immunopharmacol; 2020 Dec; 89(Pt A):107033. PubMed ID: 33039958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microwave ablation as local consolidative therapy for patients with extracranial oligometastatic EGFR-mutant non-small cell lung cancer without progression after first-line EGFR-TKIs treatment.
    Ni Y; Ye X; Yang X; Huang G; Li W; Wang J; Han X; Wei Z; Meng M
    J Cancer Res Clin Oncol; 2020 Jan; 146(1):197-203. PubMed ID: 31599340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryotherapy for nodal metastasis in NSCLC with acquired resistance to immunotherapy.
    Adam LC; Raja J; Ludwig JM; Adeniran A; Gettinger SN; Kim HS
    J Immunother Cancer; 2018 Dec; 6(1):147. PubMed ID: 30541627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Local microwave ablation with continued EGFR tyrosine kinase inhibitor as a treatment strategy in advanced non-small cell lung cancers that developed extra-central nervous system oligoprogressive disease during EGFR tyrosine kinase inhibitor treatment: A pilot study.
    Ni Y; Bi J; Ye X; Fan W; Yu G; Yang X; Huang G; Li W; Wang J; Han X; Ni X; Wei Z; Han M; Zheng A; Meng M; Xue G; Zhang L; Wan C
    Medicine (Baltimore); 2016 Jun; 95(25):e3998. PubMed ID: 27336903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The next generation of immunotherapy: keeping lung cancer in check.
    Somasundaram A; Burns TF
    J Hematol Oncol; 2017 Apr; 10(1):87. PubMed ID: 28434399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Immunometabolism Mediated by CD73 Pathway in
    Passarelli A; Aieta M; Sgambato A; Gridelli C
    Front Immunol; 2020; 11():1479. PubMed ID: 32760402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiation and immunotherapy combinations in non-small cell lung cancer.
    Azghadi S; Daly ME
    Cancer Treat Res Commun; 2021; 26():100298. PubMed ID: 33387868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Report of an abscopal effect induced by stereotactic body radiotherapy and nivolumab in a patient with metastatic non-small cell lung cancer.
    Britschgi C; Riesterer O; Burger IA; Guckenberger M; Curioni-Fontecedro A
    Radiat Oncol; 2018 May; 13(1):102. PubMed ID: 29855323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complete, Unpredictable, Multi-site Response Including Brain and Liver Metastases in a Patient With RET-rearranged Non-small-cell Lung Cancer Treated With Single-agent Immunotherapy: A Case Report.
    Riudavets M; Caramella C; Pradere P; Naltet C; Le Pechoux C; Adam J; Mabille L; Rouleau E; Besse B; Planchard D
    Clin Lung Cancer; 2021 Mar; 22(2):e215-e219. PubMed ID: 33187915
    [No Abstract]   [Full Text] [Related]  

  • 12. Real-world data on patients with metastatic non-small-cell lung cancer treated with checkpoint inhibitors in an Italian Teaching Hospital in 2015-2018.
    Veraldi M; Esposito S; Naturale MD; Oradei M; Cosco D; Francesco AE; Cicchetti A; Bidino RD
    J Oncol Pharm Pract; 2021 Jun; 27(4):877-886. PubMed ID: 32686615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Operability and Pathological Response of Non-Small Cell Lung Cancer (NSCLC) after Neoadjuvant Therapy with Immune Checkpoint Inhibition].
    Lücke E; Ganzert C; Föllner S; Wäsche A; Jechorek D; Schoeder V; Walles T; Genseke P; Schreiber J
    Pneumologie; 2020 Nov; 74(11):766-772. PubMed ID: 32820489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small cell transformation of non-small cell lung cancer on immune checkpoint inhibitors: uncommon or under-recognized?
    Sehgal K; Varkaris A; Viray H; VanderLaan PA; Rangachari D; Costa DB
    J Immunother Cancer; 2020 Jun; 8(1):. PubMed ID: 32581048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overcoming Primary Resistance to PD-1 Inhibitor With Anti-PD-L1 Agent in Squamous-Cell NSCLC: Case Report.
    Gelsomino F; Di Federico A; Filippini DM; Dall'Olio FG; Lamberti G; Sperandi F; Balacchi C; Brocchi S; Ardizzoni A
    Clin Lung Cancer; 2020 Mar; 21(2):e45-e48. PubMed ID: 31902695
    [No Abstract]   [Full Text] [Related]  

  • 16. Systemic Immune Activation and Responses of Irradiation to Different Metastatic Sites Combined With Immunotherapy in Advanced Non-Small Cell Lung Cancer.
    Wu M; Liu J; Wu S; Liu J; Wu H; Yu J; Meng X
    Front Immunol; 2021; 12():803247. PubMed ID: 34970277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiotherapy and Immunotherapy Combinations for Lung Cancer.
    Agrawal V; Benjamin KT; Ko EC
    Curr Oncol Rep; 2020 Nov; 23(1):4. PubMed ID: 33215306
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of checkpoint inhibitors in advanced non-small cell lung cancer at population level from the National Immunotherapy Registry.
    Smit HJM; Aerts J; van den Heuvel M; Hiltermann TJN; Bahce I; Smit EF; Dingemans AC; Hendriks LE; Stigt JA; Schramel FMNH; van Tinteren H; Groen HJM;
    Lung Cancer; 2020 Feb; 140():107-112. PubMed ID: 31911323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Checkpoint Blockade in Lung Cancer With Driver Mutation: Choose the Road Wisely.
    Calles A; Riess JW; Brahmer JR
    Am Soc Clin Oncol Educ Book; 2020 May; 40():372-384. PubMed ID: 32421452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunotherapy in advanced non-small-cell lung cancer with
    Liu F; Yuan X; Jiang J; Chu Q
    Immunotherapy; 2020 Nov; 12(16):1195-1207. PubMed ID: 32985295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.